Loading...
Loading...
Among the 6 tracked institutional investors we monitor, IOVA (IOVANCE BIOTHERAPEUTICS INC) is held with a combined value of $291.39M across 89,061,830 shares. The largest holder is BlackRock, Inc. with a position worth $109.09M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$291.39M
Total Shares Held
89,061,830
Institutional Holders
6
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $109.09M | 0.00% | +5.3% |
| 2 | VANGUARD GROUP INC | $74.28M | 0.00% | New |
| 3 | STATE STREET CORP | $61.24M | 0.00% | -13.5% |
| 4 | MILLENNIUM MANAGEMENT LLC | $33.04M | 0.01% | +34.8% |
| 5 | CITADEL ADVISORS LLC | $13.56M | 0.00% | -12.4% |
| 6 | FMR LLC | $173.05K | 0.00% | +58.7% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of IOVA with a position worth $109.09M, representing 0.00% of their portfolio. In total, 6 institutional investors hold IOVA with a combined value of $291.39M.
In the most recent quarter, 1 fund opened a new position in IOVA. Additionally, 3 increased their holdings and 2 reduced their positions.
Institutional investors hold $291.39M worth of IOVA stock across 6 positions. The largest institutional holder is BlackRock, Inc. with $109.09M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For IOVA, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their IOVA positions.